Responses
Abstracts Accepted for Publication
Rheumatoid arthritis - other biologic treatment
AB0451 NI-0101, a Monoclonal Antibody Targeting Toll Like Receptor 4 (TLR4) Being Developed for Rheumatoid Arthritis (RA) Treatment with a Potential for Personalized Medicine
Compose a Response to This Article
Other responses
No responses have been published for this article.